{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T13:06:53Z","timestamp":1778936813526,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","award":["203009014"],"award-info":[{"award-number":["203009014"]}],"id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","award":["300342\\u2212104"],"award-info":[{"award-number":["300342\\u2212104"]}],"id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJID Regions"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ijregi.2025.100642","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T23:18:19Z","timestamp":1743808699000},"page":"100642","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Assessing the evidence for antibiotic management of laboratory-confirmed Streptococcus A skin infections to prevent acute rheumatic fever and rheumatic heart disease: a systematic review"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2687-7751","authenticated-orcid":false,"given":"Trudy D","family":"Leong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ameer SJ","family":"Hohlfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Funeka","family":"Bango","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denny","family":"Mabetha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ntombifuthi","family":"Blose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joy","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark E","family":"Engel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara","family":"Kredo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijregi.2025.100642_sbref0001","series-title":"Rheumatic heart disease","year":"2022"},{"key":"10.1016\/j.ijregi.2025.100642_bib0002","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(05)70267-X","article-title":"The global burden of group A streptococcal diseases","volume":"5","author":"Carapetis","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijregi.2025.100642_bib0003","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136789","article-title":"The global epidemiology of impetigo: a systematic review of the population prevalence of impetigo and pyoderma","volume":"10","author":"Bowen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijregi.2025.100642_bib0004","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1093\/cid\/ciu296","article-title":"Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America","volume":"59","author":"Stevens","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijregi.2025.100642_bib0005","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2021-007038","article-title":"Preceding group A streptococcus skin and throat infections are individually associated with acute rheumatic fever: evidence from New Zealand","volume":"6","author":"Oliver","year":"2021","journal-title":"BMJ Glob Health"},{"key":"10.1016\/j.ijregi.2025.100642_bib0006","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2261-5-11","article-title":"Antibiotics for the primary prevention of acute rheumatic fever: a meta-analysis","volume":"5","author":"Robertson","year":"2005","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.ijregi.2025.100642_bib0007","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/tmi.13198","article-title":"Treatment, prevention and public health management of impetigo, scabies, crusted scabies and fungal skin infections in endemic populations: a systematic review","volume":"24","author":"May","year":"2019","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.ijregi.2025.100642_bib0008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121363","article-title":"A cost-effectiveness analysis of a program to control rheumatic fever and rheumatic heart disease in Pinar del Rio, Cuba","volume":"10","author":"Watkins","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijregi.2025.100642_bib0009","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1128\/CMR.00112-16","article-title":"Current and emerging topical antibacterials and antiseptics: agents, action, and resistance patterns","volume":"30","author":"Williamson","year":"2017","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijregi.2025.100642_bib0010","article-title":"Skin infections caused by Staphylococcus aureus","volume":"100","author":"Del Giudice","year":"2020","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.ijregi.2025.100642_bib0011","article-title":"Interventions for impetigo","volume":"1","author":"Koning","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijregi.2025.100642_bib0012","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.det.2010.09.005","article-title":"Community-associated methicillin-resistant Staphylococcus aureus skin infections in the tropics","volume":"29","author":"Tong","year":"2011","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.ijregi.2025.100642_bib0013","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.clinthera.2021.04.013","article-title":"Emerging treatment strategies for impetigo in endemic and nonendemic settings: a systematic review","volume":"43","author":"Gahlawat","year":"2021","journal-title":"Clin Ther"},{"key":"10.1016\/j.ijregi.2025.100642_bib0014","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1093\/jac\/dki387","article-title":"In vivo transfer of high-level mupirocin resistance from Staphylococcus epidermidis to methicillin-resistant Staphylococcus aureus associated with failure of mupirocin prophylaxis","volume":"56","author":"Hurdle","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijregi.2025.100642_bib0015","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13643-021-01626-4","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"10","author":"Page","year":"2021","journal-title":"Syst Rev"},{"key":"10.1016\/j.ijregi.2025.100642_bib0016","series-title":"Covidence Systematic Review Software","year":"2023"},{"key":"10.1016\/j.ijregi.2025.100642_bib0017","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.ijregi.2025.100642_bib0018","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.ijregi.2025.100642_bib0019","series-title":"Review Manager 5 (RevMan 5) [computer program]","year":"2020"},{"key":"10.1016\/j.ijregi.2025.100642_bib0020","series-title":"GRADE handbook. Grade HT","author":"Schunemann","year":"2015"},{"key":"10.1016\/j.ijregi.2025.100642_bib0021","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/jac\/31.suppl_E.129","article-title":"Once-daily azithromycin in the treatment of adult skin and skin-structure infections","volume":"31","author":"Amaya-Tapia","year":"1993","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijregi.2025.100642_bib0022","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1016\/S0140-6736(14)60841-2","article-title":"Short-course oral co-trimoxazole versus intramuscular Benzathine benzylpenicillin for impetigo in a highly endemic region: an open-label, randomised, controlled, non-inferiority trial","volume":"384","author":"Bowen","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ijregi.2025.100642_bib0023","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jpeds.2008.06.035","article-title":"Randomized, comparative efficacy trial of oral penicillin versus cefuroxime for perianal streptococcal dermatitis in children","volume":"153","author":"Meury","year":"2008","journal-title":"J Pediatr"},{"key":"10.1016\/j.ijregi.2025.100642_bib0024","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/jac\/31.suppl_E.103","article-title":"A comparative study of the efficacy, safety and tolerance of azithromycin, dicloxacillin and flucloxacillin in the treatment of children with acute skin and skin-structure infections","volume":"31","author":"Rodriguez-Solares","year":"1993","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijregi.2025.100642_bib0025","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1440-1754.2010.01697.x","article-title":"Trimethopim-sulfamethoxazole compared with benzathine penicillin for treatment of impetigo in Aboriginal children: a pilot randomised controlled trial","volume":"46","author":"Tong","year":"2010","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.ijregi.2025.100642_bib0026","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1185\/03007998609111100","article-title":"A comparison of the new topical antibiotic mupirocin ('Bactroban') with oral antibiotics in the treatment of skin infections in general practice","volume":"10","author":"Villiger","year":"1986","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ijregi.2025.100642_bib0027","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1097\/00006454-199707000-00013","article-title":"Comparison of oral cephalexin, topical mupirocin and topical bacitracin for treatment of impetigo","volume":"16","author":"Bass","year":"1997","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijregi.2025.100642_bib0028","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0149-2918(02)80024-8","article-title":"double-blind, multicenter comparison of oral cefditoren 200 or 400 mg BID with either cefuroxime 250 mg BID or cefadroxil 500 mg BID for the treatment of uncomplicated skin and skin-structure infections","volume":"24","author":"Bucko","year":"2002","journal-title":"Clin Ther"},{"key":"10.1016\/j.ijregi.2025.100642_bib0029","first-page":"36","article-title":"Clinical comparison of cefuroxime axetil, cephalexin and cefadroxil in the treatment of patients with primary infections of the skin or skin structures","volume":"183","author":"Gooch","year":"1991","journal-title":"Dermatologica"},{"key":"10.1016\/j.ijregi.2025.100642_bib0030","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1128\/AAC.36.8.1614","article-title":"Evaluation of cefuroxime axetil and cefadroxil suspensions for treatment of pediatric skin infections","volume":"36","author":"Jacobs","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijregi.2025.100642_bib0031","doi-asserted-by":"crossref","first-page":"111S","DOI":"10.1016\/0002-9343(91)90321-N","article-title":"Double-blind randomized study of oral temafloxacin and cefadroxil in patients with mild to moderately severe bacterial skin infections","volume":"91","author":"Neldner","year":"1991","journal-title":"Am J Med"},{"key":"10.1016\/j.ijregi.2025.100642_bib0032","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/01.inf.0000059403.21440.2c","article-title":"Linezolid versus cefadroxil in the treatment of skin and skin structure infections in children","volume":"22","author":"Wible","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijregi.2025.100642_bib0033","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12245-015-0060-9","article-title":"Treatment outcome measures for randomized controlled trials of antibiotic treatment for acute bacterial skin and skin structure infections in the emergency department setting","volume":"8","author":"Quirke","year":"2015","journal-title":"Int J Emerg Med"},{"key":"10.1016\/j.ijregi.2025.100642_bib0034","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.pcl.2013.12.004","article-title":"Cutaneous bacterial infections caused by Staphylococcus aureus and Streptococcus pyogenes in infants and children","volume":"61","author":"Larru","year":"2014","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.ijregi.2025.100642_bib0035","doi-asserted-by":"crossref","first-page":"e467","DOI":"10.1371\/journal.pntd.0000467","article-title":"High burden of impetigo and scabies in a tropical country","volume":"3","author":"Steer","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ijregi.2025.100642_bib0036","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.760255","article-title":"Antibiotic treatment, mechanisms for failure, and adjunctive therapies for infections by Group A streptococcus","volume":"12","author":"Johnson","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijregi.2025.100642_bib0037","doi-asserted-by":"crossref","first-page":"392","DOI":"10.4103\/0019-5359.44018","article-title":"Antibiotic resistance pattern of group-a beta-hemolytic streptococci isolated from north Indian children","volume":"62","author":"Jain","year":"2008","journal-title":"Indian J Med Sci"},{"key":"10.1016\/j.ijregi.2025.100642_bib0038","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/cid\/ciac042","article-title":"Mass drug administration for the control of scabies: a systematic review and meta-analysis","volume":"75","author":"Lake","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijregi.2025.100642_bib0039","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.03162-20","article-title":"Streptococcus pyogenes is associated with idiopathic cutaneous ulcers in children on a yaws-endemic island","volume":"12","author":"Griesenauer","year":"2021","journal-title":"mBio"}],"container-title":["IJID Regions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772707625000773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772707625000773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T12:13:40Z","timestamp":1778933620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772707625000773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":39,"alternative-id":["S2772707625000773"],"URL":"https:\/\/doi.org\/10.1016\/j.ijregi.2025.100642","relation":{},"ISSN":["2772-7076"],"issn-type":[{"value":"2772-7076","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing the evidence for antibiotic management of laboratory-confirmed Streptococcus A skin infections to prevent acute rheumatic fever and rheumatic heart disease: a systematic review","name":"articletitle","label":"Article Title"},{"value":"IJID Regions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijregi.2025.100642","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"100642"}}